Tadalafil, a phosphodiesterase-5 inhibitor, might have renoprotective effects via prevention of fibroblast to myofibroblast transition by cGMP.

○Misuzu Noda

1:30 PM - 1:42 PM

[27G-pm01S] Tadalafil, a phosphodiesterase-5 inhibitor, might have renoprotective effects via prevention of fibroblast to myofibroblast transition by cGMP.

○Misuzu Noda¹, Natsumi Tomita², Akimasa Sanagawa^1,2, Tomoya Kataoka³, Yoko Hibi^1,2, Yuji Hotta^1,2, Kazunori Kimura^1,2,3 (1. Fac. Pharm., Nagoya City Univ., 2. Grad. Sch. Pharm., Nagoya City Univ., 3. Grad. Sch. Med., Nagoya City Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[27G-pm] Kidney, urinary organs and reproductive organs

[27G-pm01S] Tadalafil, a phosphodiesterase-5 inhibitor, might have renoprotective effects via prevention of fibroblast to myofibroblast transition by cGMP.

Password